,in the ,senate of the ,united ,states1 ,june #bb1 #bjbc4 ,amendment3 ,that the bill from the ,house of ,representatives 7,h4,r4 #agcd7 entitled ,an ,act to require coordinated ,national ,institute of ,standards and ,technology science and research activities regarding illicit drugs containing xylazine1 novel synthetic opioids1 and other substances of concern1 and for other purposes41 do pass with the following ,strike all after the enacting clause and insert the following3 #a4 ,short title ,this ,act may be cited as the ,testing1 ,rapid ,analysis1 and ,narcotic ,quality ,research ,act of #bjbc or the ,,tranq ,research ,act of #bjbc4 #b4 ,xylazine detection and analysis 7a7 ,definitions ,in this section3 7#a7 ,director ,the term ,director means the ,director of the ,national ,institute of ,standards and ,technology4 7#b7 ,federal laboratory ,the term ,federal laboratory has the meaning given such term in section #d of the ,stevenson-,wydler ,technology ,innovation ,act of #aihj 7#ae ,u4,s4,c4 #cgjc74 7#c7 ,institute ,the term ,institute means the ,national ,institute of ,standards and ,technology4 7#d7 ,institution of higher education ,the term institution of higher education has the meaning given such term in section #aja of the ,higher ,education ,act of #aife 7#ai ,u4,s4,c4 #ajja74 7#e7 ,nonprofit organization ,the term nonprofit organization means an organization described in section #eja7;c77#c7 of the ,internal ,revenue ,code of #aihf and exempt from tax under section #eja7;a7 of such code4 7#f7 ,xylazine ,the term xylazine means the nonopioid tranquilizer methyl benzene compound frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties4 7b7 ,in general ,the ,director shall-- 7#a7 support intramural basic measurement science and research of the ,institute to advance-- 7,a7 analytical methods to identify1 understand1 differentiate1 and categorize substances containing xylazine1 novel synthetic opioids1 or other new psychoactive substances2 7,b7 measurement technologies to shorten analysis timelines and enhance narcotic and opioid detection and analysis capabilities2 7,c7 new data tools1 techniques1 and processes to identify and publicly disclose relevant information concerning substances containing xylazine1 novel synthetic opioids1 or other new psychoactive substances2 and 7,d7 such other areas as the ,director determines to be critical to the development and deployment of technologies to measure and analyze the presence of xylazine1 novel synthetic opioids1 and other new psychoactive substances2 7#b7 support activities to inform and expand the development of near-real time spectrometry capabilities regarding xylazine1 novel synthetic opioids1 and other new psychoactive substances2 7#c7 convene and consult with organizations engaged in the analysis of new psychoactive substances to develop coordinated strategies and voluntary best practices for the safe handling1 transport1 data-sharing1 and analysis of substances containing xylazine1 novel synthetic opioids1 or other new psychoactive substances1 including-- 7,a7 the ,drug ,enforcement ,administration2 7,b7 the ,centers for ,disease ,control and ,prevention2 7,c7 the ,national ,institute on ,drug ,abuse2 7,d7 ,federal laboratories2 7,e7 ,states and territories2 7,f7 ,state fusion centers2 7,g7 the private sector2 7,h7 intergovernmental organizations2 7,i7 institutions of higher education1 and 7,j7 nonprofit organizations2 7#d7 establish or expand collaborative partnerships or consortia with other government agencies and persons engaged in related research and development1 such as institutions of higher education1 ,federal laboratories1 public health agencies1 intergovernmental organizations1 and the private sector1 to enhance narcotic and opioid detection and analysis capabilities regarding xylazine1 novel synthetic opioids1 and other new psychoactive substances2 and 7#e7 encourage graduate and post-graduate research to include detection and identification of xylazine and other new psychoactive substances in relevant course studies when practicable4 7c7 ,controls ,in carrying out activities under this section1 the ,director shall ensure proper security controls are implemented to protect sensitive information1 as the ,director considers appropriate and consistent with applicable provisions of law4 7d7 ,report ,not later than #a year after the date of the enactment of this ,act1 the ,director shall submit to the ,committee on ,commerce1 ,science1 and ,transportation of the ,senate and the ,committee on ,science1 ,space1 and ,technology of the ,house of ,representatives a report on the implementation of this section4 ,such report may include recommendations for legislative action to improve the ability of the ,director to carry out this section4 #c4 ,study on ,united ,states ,government technologies and analytical methods to detect and identify new psychoactive substances 7a7 ,study 7#a7 ,in general ,the ,comptroller ,general of the ,united ,states shall conduct a study of the capabilities of the ,federal ,government to respond to the threats of new psychoactive substances such as xylazine4 7#b7 ,matters evaluated ,the study conducted pursuant to paragraph 7#a7 shall include an evaluation of the following3 7,a7 ,the capabilities1 including technologies and analytical methods1 of ,federal1 ,state1 and local agencies to detect and identify new psychoactive substances such as xylazine4 7,b7 ,an analysis of timeframes for identification and development of technologies and methods to identify new psychoactive substances by ,federal1 ,state1 and local agencies4 7,c7 ,facilities1 including laboratories1 used by ,federal1 ,state1 and local agencies for the identification of new psychoactive substances such as xylazine4 7,d7 ,federal grant programs to fund new technology development to detect and identify new psychoactive substances4 7b7 ,report ,not later than #b years after the date of the enactment of this ,act1 the ,comptroller ,general shall submit to the ,committee on ,commerce1 ,science1 and ,transportation of the ,senate and the ,committee on ,science1 ,space1 and ,technology of the ,house of ,representatives a report containing the findings of the ,comptroller ,general with respect to the study conducted pursuant to subsection 7a74 ,secretary